propionylcarnitine has been researched along with malondialdehyde in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou El-Naga, SA; Calvani, M; Gaballah, HE; Nicolai, R; Salman, TM; Sayed-Ahmed, MM | 1 |
| Gabriella, C; Gea, OC; Giuseppe, M; Giuseppe, P; Luigi, DP; Margherita, F; Massimiliano, A; Roberto, F; Santo, SS; Sergio, N | 1 |
| Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Massimiliano, A; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS | 1 |
| Bloomer, RJ; Smith, WA; Tschume, LC | 1 |
3 trial(s) available for propionylcarnitine and malondialdehyde
| Article | Year |
|---|---|
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD.
Topics: Aged; Aldehydes; Ankle; Blood Glucose; Blood Pressure; Brachial Artery; Carnitine; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Glycated Hemoglobin; Humans; Malondialdehyde; Middle Aged; Oxidation-Reduction; Pain Measurement; Placebos | 2006 |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
Topics: Aged; Aldehydes; Carnitine; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Oxygen; Peripheral Vascular Diseases; Placebos; Renal Dialysis; Renal Insufficiency | 2006 |
Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects.
Topics: Adolescent; Adult; Blood Cell Count; Blood Chemical Analysis; Carnitine; Cholesterol; Double-Blind Method; Exercise; Glycine; Humans; Lipid Metabolism; Malondialdehyde; Nitric Oxide; Triglycerides; Young Adult | 2009 |
1 other study(ies) available for propionylcarnitine and malondialdehyde
| Article | Year |
|---|---|
Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cardiomyopathies; Cardiotonic Agents; Carnitine; Doxorubicin; Female; Glutathione; In Vitro Techniques; Male; Malondialdehyde; Mice; Mitochondria, Heart; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2001 |